162831-31-4

Basic information

• Product Name: IEM 1754 dihydrobroMide
• Synonyms: IEM1754;N-(Tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-1,5-pentanediamine dihydrobromide;IEM 1754 2HBr;1,5-Pentanediamine, N1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-, hydrobromide (1:2);N1-((3r,5r,7r)-Adamantan-1-ylmethyl)pentane-1,5-diamine hydrobromide
• CAS NO: 162831-31-4
• Molecular Formula: C16H32Br2N2
• Molecular Weight: 412.24668
• Product Categories: Inhibitors
• Mol File: 162831-31-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: IEM 1754 dihydrobroMide(CAS DataBase Reference)
• NIST Chemistry Reference: IEM 1754 dihydrobroMide(162831-31-4)
• EPA Substance Registry System: IEM 1754 dihydrobroMide(162831-31-4)

Safety Data

• Hazardous Substances Data: 162831-31-4(Hazardous Substances Data)

Usage

Description

IEM 1754 dihydrobromide is a compound that functions as a blocker of AMPA receptors, which are ligand-gated ion channels that are voltage-dependent and open-channel. This characteristic makes it a potentially useful tool in various applications, particularly in the field of neuroscience and pharmaceutical research.

Uses

Used in Neuroscience Research:
IEM 1754 dihydrobromide is used as a research tool for studying the role of AMPA receptors in neuronal function and synaptic plasticity. By blocking these receptors, researchers can gain insights into the underlying mechanisms of various neurological processes and disorders.
Used in Pharmaceutical Development:
IEM 1754 dihydrobromide is used as a potential therapeutic agent in the development of drugs targeting AMPA receptor-mediated pathways. This application is particularly relevant for conditions such as epilepsy, where AMPA receptor antagonists have shown promise in reducing seizure activity and improving patient outcomes.
Used in Drug Delivery Systems:
In the context of drug delivery, IEM 1754 dihydrobromide can be used as a component in the design of targeted drug delivery systems. By incorporating this compound into nanoparticles or other carriers, it may be possible to enhance the delivery of therapeutic agents to specific cells or tissues, thereby improving the efficacy and safety of treatments for various conditions.
Overall, IEM 1754 dihydrobromide is a versatile compound with potential applications in neuroscience research, pharmaceutical development, and drug delivery systems, all due to its ability to block AMPA receptors in a voltage-dependent and open-channel manner.